Cancer vaccines consist of one or more antigenic components, including live-attenuated or killed viral or bacterial particles, proteins, polysaccharides, polynucleotides, and particle conjugates. Additionally, other excipients like adjuvants may be present. Not only the chemical and structural integrity of various components must be maintained, but the immunogenicity must be ensured. Thus, the complexity of vaccines creates a unique challenge for characterization. Learn more about GMP cancer vaccine analysis: https://www.creative-biolabs.com/car-t/gmp-cancer-vaccine-analysis-and-qualification.htm